Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals | Zendy

Arkaitz Imaz | Zendy; Josep M. Llibre | Zendy; Marta Mora-Rillo | Zendy; Gràcia Mateo | Zendy; Ángela Camacho | Zendy; José Ramón Blanco | Zendy; Adrián Curran | Zendy; José Ramón Santos | Zendy; E. Caballero | Zendy; Isabel Bravo | Zendy; Francisco Gayá | Zendy; Peré Domingo | Zendy; Antonio Rivero | Zendy; Vicenç Falcó | Zendy; B. Clotet | Zendy; Esteban Ribera | Zendy

Open Access

Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals

Author(s) -

Arkaitz Imaz,

Josep M. Llibre,

Marta Mora-Rillo,

Gràcia Mateo,

Ángela Camacho,

José Ramón Blanco,

Adrián Curran,

José Ramón Santos,

E. Caballero,

Isabel Bravo,

Francisco Gayá,

Peré Domingo,

Antonio Rivero,

Vicenç Falcó,

B. Clotet,

Esteban Ribera

Publication year - 2010

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkq432

Subject(s) - raltegravir , etravirine , medicine , regimen , salvage therapy , maraviroc , adverse effect , darunavir , viral load , nucleoside reverse transcriptase inhibitor , drug resistance , confidence interval , reverse transcriptase inhibitor , virology , pharmacology , human immunodeficiency virus (hiv) , chemotherapy , antiretroviral therapy , biology , microbiology and biotechnology

The advent of new antiretrovirals has expanded the therapeutic options for multiple drug-resistant HIV-1 infection. The role of recycled nucleoside reverse transcriptase inhibitors (NRTIs) in this scenario remains uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research